The global protein labeling market size was valued at USD 1.8 billion in 2019 and is expected to expand at a compound annual growth rate (CAGR) of 7% from 2021 to 2027. Increasing R&D spending for proteomics research supports protein analysis. The demand for protein labeling technology. This increase in R&D expenditure has benefited the field of proteomics by expanding the application of mass spectrometry, protein microarrays and biochips in this field. In addition, improvements in mass spectrometry workflows and miniaturization of biochips drive proteomics applications, consequently driving organic revenue growth in the market.
A full report of Protein Labeling Market available at https://www.orionmarketreports.com/protein-labeling-market/10884/
Protein Labeling Market Segmentations
By Product
• Reagentsac
• Kits
• Services
By Application
• Cell-Based Assays
• Fluorescence Microscopy
• Immunological Techniques
• Mass Spectrometry
• Protein Microarray
By Labeling Method
• In Vitro Labeling Methods
• In Vivo Labeling Methods
• Bioorthogonal Labeling
Company Profiles
• Thermo Fisher Scientific, Inc.
• Merck KGaA
• Perkin Elmer, Inc.
• Promega Corporation
• F. Hoffmann-La Roche Ltd.
• LGC Limited
• New England Biolabs
• LI-COR, Inc.
• GE Healthcare
• Jena Bioscience GmbH
(This release has been published on OMR Industry Journal. OMR Industry Journal is not responsible for any content included in this release.)
